Pharmaceutical companies share information with anti-doping agencies

Nowadays a lot of drug manufacturers are ready to cooperate with anti-doping officials in their fight against application of prohibited medications in sports. It sounds strange but this is the reality. In fact, if you review the fate of EPO, you can comprehend why pharmaceutical companies agree to support efforts of anti-doping officers. EPO is actually an efficient remedy for treatment of anemia. Numerous individuals with anemia that have used EPO have been treated. But what do you think while hearing about this drug? Almost each person associates this remedy only with doping in sports. This product has been abused by the American cyclist Lance Armstrong that has cheated the whole world. So, EPO is associated just with cheating, shame, etc. Looking at this case, drug manufacturers try to “defend” their preparations from the similar fate. That’s why they collaborate with anti-doping officials.
Although certain drug manufacturers began to collaborate with anti-doping officials earlier, sometimes there were several problems between them. Anti-doping officers criticized several pharmaceutical companies for their connections with doping.
Today relations between anti-doping agencies and pharmaceutical companies are better. Pharmaceutical companies share detailed information about new preparations with anti-doping agencies. It is precious information for development of detection tests for these preparations. While anti-doping officials learn how preparations are manufactured, how they pass into body, how they work in the body, they can develop more effectual tests for these drugs.
For example, the pharmaceutical company Roche that developed the medicine CERA helped anti-doping officers to introduce a detection test for it. Later other drug manufacturers followed the example of Roche. The drug manufacturer GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping officials and big pharmaceutical companies become closer, smaller drug manufacturers begin to cooperate with anti-doping officials too. While earlier pharmaceutical companies haven’t desired to discuss about their links to anti-doping officers openly, now they don’t fear to announce about this aspect.